Clin2
NCT07432698Likely a fitNot yet recruiting

Safety study of AK0406 injection in healthy adults

Healthy Participants

Treatments studied

This study tests a new medicine called AK0406, given as an injection, to see if it is safe and how the body handles it in healthy volunteers. It helps find the right dose for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You are in good general health with no major medical conditions.
  • Your weight is at least 50 kg (men) or 45 kg (women), with a body mass index between 18 and 32.
  • You agree to use highly effective birth control for 6 months after the injection (if applicable).
  • You have no history of cancer, bleeding disorders, or severe allergies.
  • You test negative for HIV, hepatitis B/C, and syphilis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07419698Recruiting· Phase 1
Safety study of JMT206 injection in healthy volunteers

This early-stage trial tests a new medicine called JMT206 in healthy people to see if it is safe and how the body handles it. Healthy volunteers, ages 18 to 60, are needed to help researchers learn about the drug's effects and how it moves through the body.

Beijing, Beijing Municipality
NCT06760455Recruiting· Phase 1
Safety of BPR-30221616 Injection in Healthy People

This study tests a new injection called BPR-30221616 to see how safe it is and how people tolerate it. It is for healthy volunteers and will help find the right dose for future studies.

Beijing, Beijing Municipality
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07757659Not yet recruiting· Phase 1
Study of XKH001 for healthy adults

This trial is testing a new study drug called XKH001 in healthy volunteers to see how it affects the body. It is the first time this drug is being studied in people of European descent.

Melbourne
NCT06996704Recruiting· Phase 1
Study of AK0610 in healthy adults

This trial tests a new drug called AK0610 in healthy volunteers aged 18 to 50. It helps researchers understand how the drug works in the body and whether it is safe before moving to larger studies.

Jinan, Shandong
NCT07474545Recruiting· Phase 1
Safety study of KL0011034 injection in healthy volunteers

This trial tests a new injection called KL0011034 to see if it is safe and how the body processes it. Healthy volunteers aged 18–45 who meet specific health and lifestyle criteria can join.

Changsha, Hunan

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.